Skip to main content
Quest Diagnostics Home

Fighting the Ladykiller (and side effects) with Cholesterol Lowering Therapy

On-Demand Webinar

duration: 45 minutes

Topics:

Health & Wellness

Fighting the Ladykiller (and side effects) with Cholesterol Lowering Therapy

 

This webcast will focus on lowering cardiovascular risk in women through effective cholesterol management and addressing issues like statin myalgias.

 

Learning objectives:

  • —Provide two examples why management of cholesterol is different in women compared to men.
  • —List 4 classifications of patients who qualify for statin therapy.
  • —Describe 2 clinical pearls to improve statin associated muscle symptoms.

 

Presenter: Margo Minissian, PhD, ACNP, FNLA, FAHA
Research Scientist, Clinical Lipid Specialist, Cardiology Nurse Practitioner; Fellow of the National Lipid Association; Fellow of the American Heart Association, Barbra Streisand Women’s Heart Center at the Smidt Cedars-Sinai Heart Institute; Los Angeles, California

 

Time of talk: 45 minutes

This enduring material activity, Fighting the Ladykiller (and side effects) with Cholesterol Lowering Therapy, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins October 12, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Page Published: October 17, 2023

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2023 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.